论文部分内容阅读
侵袭性垂体腺瘤是临床实践中的一个重要难题,诊断标准不统一,治疗效果较差,术后容易复发,常需要进行综合性治疗。目前侵袭性垂体腺瘤的诊断多是根据Hardy影像学分类法来判断。具体治疗方案,可根据肿瘤类型不同,采取个性化治疗,从而提高治疗效果和减少并发症的发生。近年来,随着分子生物学以及临床研究的不断进展,新的治疗方法、治疗药物的不断出现,以及一些辅助设备如神经内窥镜、术中影像及术中导航在临床上的应用,极大地提高了侵袭性垂体腺瘤的临床诊断及治疗水平。
Invasive pituitary adenoma is an important problem in clinical practice, diagnostic criteria are not uniform, poor treatment, postoperative recurrence, often require a comprehensive treatment. At present, the diagnosis of invasive pituitary adenoma is mostly based on Hardy’s imaging classification. Specific treatment options, according to the different tumor types, to take personalized treatment, thereby enhancing the therapeutic effect and reduce the incidence of complications. In recent years, with the continuous progress of molecular biology and clinical research, new treatment methods, the emergence of therapeutic drugs, as well as some auxiliary equipment such as neuroendoscopy, intraoperative imaging and intraoperative navigation in clinical applications, The earth raised the clinical diagnosis and treatment of invasive pituitary adenoma.